
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Structure-based classification of tauopathies
Yang Shi, Wenjuan Zhang, Yang Yang, et al.
Nature (2021) Vol. 598, Iss. 7880, pp. 359-363
Open Access | Times Cited: 619
Yang Shi, Wenjuan Zhang, Yang Yang, et al.
Nature (2021) Vol. 598, Iss. 7880, pp. 359-363
Open Access | Times Cited: 619
Showing 1-25 of 619 citing articles:
Cryo-EM structures of amyloid-β 42 filaments from human brains
Yang Yang, Diana Arseni, Wenjuan Zhang, et al.
Science (2022) Vol. 375, Iss. 6577, pp. 167-172
Open Access | Times Cited: 352
Yang Yang, Diana Arseni, Wenjuan Zhang, et al.
Science (2022) Vol. 375, Iss. 6577, pp. 167-172
Open Access | Times Cited: 352
Structures of α-synuclein filaments from human brains with Lewy pathology
Yang Yang, Yang Shi, Manuel Schweighauser, et al.
Nature (2022) Vol. 610, Iss. 7933, pp. 791-795
Open Access | Times Cited: 279
Yang Yang, Yang Shi, Manuel Schweighauser, et al.
Nature (2022) Vol. 610, Iss. 7933, pp. 791-795
Open Access | Times Cited: 279
The expanding amyloid family: Structure, stability, function, and pathogenesis
M.R. Sawaya, Michael P. Hughes, José A. Rodríguez, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 4857-4873
Open Access | Times Cited: 272
M.R. Sawaya, Michael P. Hughes, José A. Rodríguez, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 4857-4873
Open Access | Times Cited: 272
The molecular basis for cellular function of intrinsically disordered protein regions
Alex S. Holehouse, Birthe B. Kragelund
Nature Reviews Molecular Cell Biology (2023) Vol. 25, Iss. 3, pp. 187-211
Open Access | Times Cited: 235
Alex S. Holehouse, Birthe B. Kragelund
Nature Reviews Molecular Cell Biology (2023) Vol. 25, Iss. 3, pp. 187-211
Open Access | Times Cited: 235
Structure of pathological TDP-43 filaments from ALS with FTLD
Diana Arseni, Masato Hasegawa, Alexey G. Murzin, et al.
Nature (2021) Vol. 601, Iss. 7891, pp. 139-143
Open Access | Times Cited: 211
Diana Arseni, Masato Hasegawa, Alexey G. Murzin, et al.
Nature (2021) Vol. 601, Iss. 7891, pp. 139-143
Open Access | Times Cited: 211
Assembly of recombinant tau into filaments identical to those of Alzheimer’s disease and chronic traumatic encephalopathy
Sofia Lövestam, Fujiet Adrian Koh, Bart van Knippenberg, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 206
Sofia Lövestam, Fujiet Adrian Koh, Bart van Knippenberg, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 206
Tauopathies: new perspectives and challenges
Yi Zhang, Kaimin Wu, Yang Liu, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 187
Yi Zhang, Kaimin Wu, Yang Liu, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 187
Age-dependent formation of TMEM106B amyloid filaments in human brains
Manuel Schweighauser, Diana Arseni, Mehtap Bacioglu, et al.
Nature (2022) Vol. 605, Iss. 7909, pp. 310-314
Open Access | Times Cited: 144
Manuel Schweighauser, Diana Arseni, Mehtap Bacioglu, et al.
Nature (2022) Vol. 605, Iss. 7909, pp. 310-314
Open Access | Times Cited: 144
Cellular and pathological heterogeneity of primary tauopathies
Dah‐eun Chloe Chung, Shanu F. Roemer, Leonard Petrucelli, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 140
Dah‐eun Chloe Chung, Shanu F. Roemer, Leonard Petrucelli, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 140
Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43
Yi Jiang, Qin Cao, M.R. Sawaya, et al.
Nature (2022) Vol. 605, Iss. 7909, pp. 304-309
Open Access | Times Cited: 125
Yi Jiang, Qin Cao, M.R. Sawaya, et al.
Nature (2022) Vol. 605, Iss. 7909, pp. 304-309
Open Access | Times Cited: 125
Chronic traumatic encephalopathy (CTE): criteria for neuropathological diagnosis and relationship to repetitive head impacts
Ann C. McKee, Thor D. Stein, Bertrand R. Huber, et al.
Acta Neuropathologica (2023) Vol. 145, Iss. 4, pp. 371-394
Open Access | Times Cited: 122
Ann C. McKee, Thor D. Stein, Bertrand R. Huber, et al.
Acta Neuropathologica (2023) Vol. 145, Iss. 4, pp. 371-394
Open Access | Times Cited: 122
CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease
Kanta Horie, Gemma Salvadó, Nicolas R. Barthélemy, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 1954-1963
Open Access | Times Cited: 120
Kanta Horie, Gemma Salvadó, Nicolas R. Barthélemy, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 1954-1963
Open Access | Times Cited: 120
Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids
Sjors H. W. Scheres, Benjamin Falcon, Michel Goedert
Nature (2023) Vol. 621, Iss. 7980, pp. 701-710
Closed Access | Times Cited: 115
Sjors H. W. Scheres, Benjamin Falcon, Michel Goedert
Nature (2023) Vol. 621, Iss. 7980, pp. 701-710
Closed Access | Times Cited: 115
Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target Tauopathies
Galina Limorenko, Hilal A. Lashuel
Chemical Society Reviews (2021) Vol. 51, Iss. 2, pp. 513-565
Open Access | Times Cited: 114
Galina Limorenko, Hilal A. Lashuel
Chemical Society Reviews (2021) Vol. 51, Iss. 2, pp. 513-565
Open Access | Times Cited: 114
Tau liquid–liquid phase separation in neurodegenerative diseases
Solomiia Boyko, Witold K. Surewicz
Trends in Cell Biology (2022) Vol. 32, Iss. 7, pp. 611-623
Open Access | Times Cited: 113
Solomiia Boyko, Witold K. Surewicz
Trends in Cell Biology (2022) Vol. 32, Iss. 7, pp. 611-623
Open Access | Times Cited: 113
Mechanisms and pathology of protein misfolding and aggregation
Nikolaos Louros, Joost Schymkowitz, Frédéric Rousseau
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 12, pp. 912-933
Closed Access | Times Cited: 113
Nikolaos Louros, Joost Schymkowitz, Frédéric Rousseau
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 12, pp. 912-933
Closed Access | Times Cited: 113
Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases
Andrew Chang, Xinyu Xiang, Jing Wang, et al.
Cell (2022) Vol. 185, Iss. 8, pp. 1346-1355.e15
Open Access | Times Cited: 110
Andrew Chang, Xinyu Xiang, Jing Wang, et al.
Cell (2022) Vol. 185, Iss. 8, pp. 1346-1355.e15
Open Access | Times Cited: 110
Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles
Linda Wordeman, Juan Jesus Vicente
Cancers (2021) Vol. 13, Iss. 22, pp. 5650-5650
Open Access | Times Cited: 107
Linda Wordeman, Juan Jesus Vicente
Cancers (2021) Vol. 13, Iss. 22, pp. 5650-5650
Open Access | Times Cited: 107
2.7 Å cryo-EM structure of ex vivo RML prion fibrils
Szymon W. Manka, Wenjuan Zhang, Adam Wenborn, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 107
Szymon W. Manka, Wenjuan Zhang, Adam Wenborn, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 107
Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies
Pedro Magalhães, Hilal A. Lashuel
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 96
Pedro Magalhães, Hilal A. Lashuel
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 96
Disease-Modifying Therapies for Alzheimer's Disease: More Questions than Answers
Todd E. Golde
Neurotherapeutics (2022) Vol. 19, Iss. 1, pp. 209-227
Open Access | Times Cited: 86
Todd E. Golde
Neurotherapeutics (2022) Vol. 19, Iss. 1, pp. 209-227
Open Access | Times Cited: 86
Accelerating Alzheimer’s therapeutic development: The past and future of clinical trials
Adam L. Boxer, Reisa A. Sperling
Cell (2023) Vol. 186, Iss. 22, pp. 4757-4772
Open Access | Times Cited: 82
Adam L. Boxer, Reisa A. Sperling
Cell (2023) Vol. 186, Iss. 22, pp. 4757-4772
Open Access | Times Cited: 82
Disease-specific tau filaments assemble via polymorphic intermediates
Sofia Lövestam, David Li, Jane L. Wagstaff, et al.
Nature (2023) Vol. 625, Iss. 7993, pp. 119-125
Open Access | Times Cited: 79
Sofia Lövestam, David Li, Jane L. Wagstaff, et al.
Nature (2023) Vol. 625, Iss. 7993, pp. 119-125
Open Access | Times Cited: 79
Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases
Dan Li, Cong Liu
Nature reviews. Neuroscience (2022) Vol. 23, Iss. 9, pp. 523-534
Closed Access | Times Cited: 78
Dan Li, Cong Liu
Nature reviews. Neuroscience (2022) Vol. 23, Iss. 9, pp. 523-534
Closed Access | Times Cited: 78
Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy
Shanu F. Roemer, Lea T. Grinberg, John F. Crary, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 4, pp. 603-614
Open Access | Times Cited: 78
Shanu F. Roemer, Lea T. Grinberg, John F. Crary, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 4, pp. 603-614
Open Access | Times Cited: 78